High Voltage Transmission Line
We have got 220kV Transmission Line Steel Pole Quality Certificate
from Power Industry Steel Tower Qualified Inspection & Test Center
from 2001 year.
Our steel poles are made from quality sheet through bending, forming,
automatic welding and hot galvanization. We can reach one-run machining
length of 14m and can bend sheet of thickness up to 45mm. We adopt
advanced welding procedures, automatically weld main joints and reach
rank-II welding quality. We supply more than 4000ton Substation
Structure for our clients every year.
Transmission Line Steel Pole, Utility Pole, Steel Tubular Pole, High Voltage Transmission Line Jiangsu Xinjinlei Steel Industry Co., Ltd. , https://www.steelpolejl.com
In December last year, the Health and Family Planning Commission announced the rational use of drugs 10 core information, the media continued to call for vigilance over medical care, promote the rational use of drugs, especially on the "oral can not be intramuscular injection, can not intramuscular injection" voice is very strong. How the "principles" have been landed, whether relevant policies and regulations have been introduced, and what impact it will have on hospitals and pharmaceutical companies deserves sustained attention.
New GMP falls behind the first curtain industry consolidation is expected to speed up January 1, the new version of GMP certification fell to the first curtain, 523 sterile pharmaceutical companies failed to pass certification, all were asked to suspend production. The industry agrees that the new version of GMP certification is no different from the “test of death and death†of domestic pharmaceutical manufacturers, and also a “big reshuffle†of the pharmaceutical industry. What will happen to non-certified companies in the future will trigger heated discussions in the media.
Some industry analysts believe that some small companies with weaker capital are facing a life and death crisis, but the value of these companies' products still exists, creating a good opportunity for mergers and acquisitions for large pharmaceutical companies.
"Securities Daily" believes that any industry feast is not a feast of all companies in the industry, it must be a ready, capable "strong". The reshuffle of the pharmaceutical industry has come, and there are still pharmaceutical companies that are lucky enough to try to get through, or will become targets of mergers, and the future pharmaceutical market will be rewritten accordingly.
The introduction of public health rules for the introduction of private capital will trigger the merger and acquisition of hospitals. On the 9th, the National Health and Planning Commission and the State Administration of Traditional Chinese Medicine formally released the “Some Opinions on Accelerating the Development of Socially Operating Medicine†on the 9th, requesting priority support for social capital. Non-profit medical institutions have accelerated the formation of a social medical system supplemented by non-profit medical institutions and for-profit medical institutions.
Industry insiders pointed out that this is the first time that the Health and Family Planning Commission has introduced a practical, easy-to-operate policy to develop socially-run hospitals. The introduction of this policy will attract a wave of investment and mergers and acquisitions in the medical services market.
In October 2013, the State Council’s “Several Opinions on Promoting the Development of the Health Service Industry†proposed that by 2020, a health service system covering the entire life cycle will be basically established, and the total scale of the health service industry will be more than 8 trillion yuan. With the introduction of the policy dividend, A-share pharmaceutical companies began to accelerate the influx of Nuggets in the medical services market, setting off a hospital merger and acquisition feast.
There is no lack of cold attitude in the boom. Zhu Hengpeng, director of the Center for Public Policy Studies of the Institute of Economic Research of the Chinese Academy of Social Sciences, believes that the "Opinions" have progressed, but still emphasizes that the planned economy of regional health planning and equipment allocation planning, etc., is essentially to give "principle affirmation, There is enough room for negation.
The National Health and Family Planning Commission held a press conference to announce the Top Ten News of China's Health and Family Planning in 2013 on the morning of the 7th.
1. The establishment of the National Health and Family Planning Commission;
2. The Party Central Committee and the State Council have carried out comprehensive deployments of deepening medical reforms;
3. Adhere to the basic national policy of family planning, start the implementation of a separate two-child policy;
4. Properly respond to H7N9 outbreaks and other public health emergencies;
5. Further expand the cooperation for foreign aid and aid, and the 50th Anniversary series of commemorative activities organized by the Chinese Foreign Aid Medical Team will be held;
6. Intensively carry out the party's mass line education and practice activities, and obtain effective results in the "health action for serving the people";
7. The social maintenance fee collection has triggered hot debates. The National Health and Family Planning Commission requires that all areas be regulated and managed;
8. Crack down on illegal crimes involving medical practitioners and carry out special actions to maintain medical order;
9. China attaches great importance to AIDS prevention and control work;
10. The China Affairs Office issued a leading cadre to take the lead in smoking bans, and Chinese residents' health literacy improved steadily.
Mao Qun, director of the Publicity Division of the National Health and Family Planning Commission, summed up the relevant work of the Health and Family Planning Commission in 2013 with the words “reform, innovation, and hard workâ€.
Among them, the inclusion of "separate two children" triggered widespread public opinion. Mao Qun'an stated that the "separate two-child" policy is a milestone adjustment of China's family planning policy and is being actively promoted throughout the country.
GlaxoSmithKline again "provoked the scourge" New Contac to become a raw material for poisoning Recently, Boshe Village, "the first poisonous village" was jointly investigated by several departments in Guangdong Province, confiscating nearly three tons of ice and 260 kg of K powder. Over 100 tons of raw materials for the production of poisons. According to information subsequently released by the police, the cold medicine "Contac" produced by GSK's joint venture company in China, China and the United States, became an important raw material for the production of drugs.
It is reported that the content of ephedrine contained in each new Contac is higher than other brands. Scientifically speaking, the chemical conversion from the drug Contac to the drug methamphetamine is not complicated.
In fact, since 2012, regulations have been introduced throughout the country to strengthen the management and control of ephedrine cold medicines, and to purchase "real-name system" to control the source of raw materials. However, the frequent occurrence of "production of drugs" still exposes loopholes in the existing regulatory system.
According to Sun Zhongshi, an expert in the national monitoring system for rational drug use by the Health and Welfare Commission, Xin Kang Taike is effective and reasonably safe. There is no problem with the drug itself. Currently, it will not be banned. However, further strengthening sales management, especially pharmacy management, is necessary.
In response to a number of media interviews, GSK China stated that in order to combat criminal activities and ensure that the order quantity is in line with market demand, the company has adopted a series of countermeasures such as managing factory PSE warehousing, monitoring sales supply chains, and strictly controlling dealer demand. GSK China also stressed that the dose of pseudoephedrine hydrochloride in New Contac is fully in line with the Chinese Pharmacopoeia standards and the company is working hard to develop an effective formula that will replace pseudoephedrine hydrochloride in the future, but it does not mean that New Contac will stop selling.
Over-medical serious public media appeals for rational use of drugs. On January 9th, CCTV News and @People's Daily published microblogging, pointing out that the infusion hall is overcrowded and overly severe in medicine, again emphasizing minor infusions, harmful and unprofitable. “If you don’t need drugs, you don’t need them. , can not use less to use; can not oral intramuscular injection, intramuscular injection can not infusion. "
In the afternoon of the same day, @People's Daily issued a microblog again, saying that "infusion is a minor operation": Infusion, medically invasive operation, because it needs to pierce the blood vessels to enter something that does not belong to the blood vessels. Intravenous infusion is recognized as the most dangerous method of administration. If the patient's gastrointestinal function is normal, oral medication should be the first choice; only patients with dysphagia, severe malabsorption, etc., should choose intravenous injection.
The relevant microblogs were forwarded more than 60,000 times, and many netizens agreed.
There were different voices on the evening of the 9th. The Sina Weibo user who is certified as “Surgical attending physician at the Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine†said that there is a 20-year-old patient with periodic paralysis whose blood potassium is too low and may lead to cardiac arrest and death at any time. Potassium infusion is a matter of no delay.
However, the patient read the above Weibo, refused to infusion, is persuading. @White Bobcat has questioned this question. If the patient died of refusal of infusion, can he be held accountable to the media? The Weibo was forwarded more than 1,700 times, causing some netizens to argue about media reports and doctor-patient relationship.
Since the Health and Planning Commission announced in December last year, 10 major core information on rational drug use, the principle of "can be administered orally without intramuscular injection and intramuscular injection without infusion" has triggered widespread discussion of public opinion. While the principle has been generally welcomed, it also presents the concern of "whether it will only be a slogan," "whether the hospital can implement it," or "wouldn't be innocent if it doesn't work well." How to truly implement the principle, how to "prescribe the right medicine" in the implementation, avoid food waste, and how to make the public to use the concept of rational drug use, also need to give more efforts.
At the beginning of the year, a number of policies continued to be issued centrally to lay the foundation for the industry's direction in 2014. The new version of GMP has stopped 40% of aseptic drug companies, the introduction of social rules for medical treatment, and the “Drug Administration Law†to issue opinions... The industry generally believes that the industry will embrace changes under the influence of a series of new policies, mergers of pharmaceutical companies and hospitals. The tide of integration may be opened.